136 related articles for article (PubMed ID: 1980408)
1. In vivo biliary excretion and in vitro cellular accumulation of thyroxine by rats or cultured rat hepatocytes treated with a novel histamine H1-receptor antagonist.
Poole A; Pritchard D; Jones RB; Catto L; Leonard T
Arch Toxicol; 1990; 64(6):474-81. PubMed ID: 1980408
[TBL] [Abstract][Full Text] [Related]
2. In vitro accumulation of thyroid hormones by cultured rat hepatocytes and the biliary excretion of iodothyronines in rats treated with a novel histamine H2-receptor antagonist.
Poole A; Jones RB; Pritchard D; Catto L; Leonard T
Toxicology; 1989 Nov; 59(1):23-36. PubMed ID: 2573172
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic investigation of species-specific thyroid lesions induced by treatment with the histamine H1 antagonist temelastine (SK&F 93944) in rats.
Atterwill CK; Poole A; Jones C; Jones R; Brown C
Food Chem Toxicol; 1989 Oct; 27(10):681-90. PubMed ID: 2481636
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of temelastine (SK&F 93944) in hepatocytes from rat, dog, cynomolgus monkey and man.
Oldham HG; Standring P; Norman SJ; Blake TJ; Beattie I; Cox PJ; Chenery RJ
Drug Metab Dispos; 1990; 18(2):146-52. PubMed ID: 1971564
[TBL] [Abstract][Full Text] [Related]
5. Modulation of thyroxine uptake and efflux in vitro by temelastine and phenobarbital in cultured hepatocytes from different species, in relation to toxicological effects on the thyroid gland.
Aylward SP; Walker TM; Atterwill CK
Toxicol In Vitro; 1994 Jun; 8(3):309-16. PubMed ID: 20692921
[TBL] [Abstract][Full Text] [Related]
6. Hepatobiliary disposition of thyroid hormone in Mrp2-deficient TR- rats: reduced biliary excretion of thyroxine glucuronide does not prevent xenobiotic-induced hypothyroidism.
Lecureux L; Dieter MZ; Nelson DM; Watson L; Wong H; Gemzik B; Klaassen CD; Lehman-McKeeman LD
Toxicol Sci; 2009 Apr; 108(2):482-91. PubMed ID: 19211616
[TBL] [Abstract][Full Text] [Related]
7. Comparative toxicology of temelastine. A novel H1 antagonist in dog, rat, and monkey.
Poole A; Betton GR; Salmon G; Sutton T; Atterwill CK
Fundam Appl Toxicol; 1990 Jan; 14(1):71-83. PubMed ID: 1968406
[TBL] [Abstract][Full Text] [Related]
8. Effects of propylthiouracil on the biliary clearance of thyroxine (T4) in rats: decreased excretion of 3,5,3'-triiodothyronine glucuronide and increased excretion of 3,3',5'-triiodothyronine glucuronide and T4 sulfate.
Rutgers M; Pigmans IG; Bonthuis F; Docter R; Visser TJ
Endocrinology; 1989 Oct; 125(4):2175-86. PubMed ID: 2791984
[TBL] [Abstract][Full Text] [Related]
9. Comparison of biliary excretion of iodothyronines after intravenous and intraduodenal administration of various doses of T4 and T3.
Langer P; Földes O; Gschwendtová K
Endocrinol Exp; 1984 Dec; 18(4):223-31. PubMed ID: 6335082
[TBL] [Abstract][Full Text] [Related]
10. In vivo study of iodothyronine deiodination in rat liver: effect of salicylate on biliary excretion of several iodothyronines.
Földes O; Langer P; Straussová K; Brozmanová H; Gschwendtová K
Horm Metab Res; 1983 Mar; 15(3):147-50. PubMed ID: 6852770
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological studies with SK&F 93944 (temelastine), a novel histamine H1-receptor antagonist with negligible ability to penetrate the central nervous system.
Brown EA; Griffiths R; Harvey CA; Owen DA
Br J Pharmacol; 1986 Mar; 87(3):569-78. PubMed ID: 2879585
[TBL] [Abstract][Full Text] [Related]
12. The interaction of temelastine with cytochrome P450 mixed-function oxidase enzymes in vivo and in vitro.
Chenery RJ; Cox PJ; Rath LC; Standring P; Oldham HG
Biochem Pharmacol; 1989 Jan; 38(1):209-13. PubMed ID: 2562918
[No Abstract] [Full Text] [Related]
13. Increased hepatobiliary clearance of unconjugated thyroxine determines DMP 904-induced alterations in thyroid hormone homeostasis in rats.
Wong H; Lehman-McKeeman LD; Grubb MF; Grossman SJ; Bhaskaran VM; Solon EG; Shen HS; Gerson RJ; Car BD; Zhao B; Gemzik B
Toxicol Sci; 2005 Apr; 84(2):232-42. PubMed ID: 15673846
[TBL] [Abstract][Full Text] [Related]
14. Temelastine, a novel histamine H1-receptor antagonist, does not induce oxidative hepatic enzyme activity in man.
de Mey C; Meineke I; Wesche H
Eur J Drug Metab Pharmacokinet; 1987; 12(1):65-9. PubMed ID: 2886338
[TBL] [Abstract][Full Text] [Related]
15. Evidence for low brain penetration by the H1-receptor antagonist temelastine (SK&F 93944).
Calcutt CR; Ganellin CR; Jackson B; Leigh BK; Owen DA; Smith IR
Eur J Pharmacol; 1987 Jan; 133(1):65-74. PubMed ID: 2881790
[TBL] [Abstract][Full Text] [Related]
16. Effect of ethanol and linoleic acid on changes in biliary excretion of iodothyronines possibly related to thyroxine deiodination in rat liver.
Langer P; Földes O; Gschendtová K
Horm Metab Res; 1988 Apr; 20(4):218-20. PubMed ID: 3397033
[TBL] [Abstract][Full Text] [Related]
17. Effect of the glycogenolytic gluconeogenetic hormones, glucagon, vasopressin and angiotensin II, on biliary excretion of iodothyronines in rats is possibly related to the inhibition of 5'-monodeiodination in the liver.
Langer P; Földes O; Gschwendtová K
J Endocrinol; 1989 May; 121(2):299-302. PubMed ID: 2754363
[TBL] [Abstract][Full Text] [Related]
18. Preliminary observations on the absorption of biliary iodothyronines from the intestine in vivo in rats.
Langer P; Földes O; Straussová K; Gschwendtová K
Endocrinol Exp; 1982 Jun; 16(2):117-27. PubMed ID: 6980784
[TBL] [Abstract][Full Text] [Related]
19. Temelastine, a new H1-receptor antagonist.
Alexander F; Stote RM; Allison N; Familiar RG; Tatoian D; Dubb JW
J Int Med Res; 1986; 14(4):200-4. PubMed ID: 2875907
[TBL] [Abstract][Full Text] [Related]
20. Effect of different beta-blocking drugs and adrenaline on the conversion of thyroxine to triiodothyronine in isolated rat hepatocytes.
Aanderud S; Aarbakke J; Sundsfjord J
Horm Metab Res; 1986 Feb; 18(2):110-3. PubMed ID: 2870969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
